Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma

被引：1
|
作者：
Ebia, Matthew I. [1 ]
Hitchins, Megan P. [2 ]
Hendifar, Andrew E. [1 ,3 ,4 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA USA
[3] Cedars Sinai Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, 8700 Beverly Blvd,Suite 1042AC, Los Angeles, CA 90048 USA
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2023年 / 14卷 / 02期
关键词：
Pancreatic ductal adenocarcinoma (PDAC); DNA deficient mismatch repair (DNA dMMR); microsatellite instability (MSI); Lynch syndrome; immunotherapy; CANCER;
D O I：
10.21037/jgo-23-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：1175 / 1177
页数：3
相关论文
共 50 条
  • [41] Neoadjuvant chemo-immunotherapy in mismatch repair deficient (dMMR)/microsatellite instability (MSI) gastric carcinoma (GC): A multicenter retrospective study
    Sun, H.
    Moiseyenko, V.
    Chubenko, V.
    Gerk, I.
    Navmatulya, A.
    Shelekhova, K. V.
    Volkov, N. M.
    Zykov, E.
    Chernobrivceva, V.
    Nered, S.
    Besova, N.
    Obarevich, E.
    Gavrilova, D.
    Kononets, P.
    Stilidi, I.
    Belyak, N.
    Orlova, R. V.
    Topuzov, E.
    Pelipas, Y.
    Tryakin, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S180 - S181
  • [42] Feasibility of non-operative management in patients with localized mismatch repair deficient (dMMR) gastrointestinal (GI) cancer receiving immunotherapy (IO)
    Chakrabarti, S.
    Selfridge, J. E.
    Steinhagen, E.
    Lumish, M.
    Bajor, D.
    Conces, M. L.
    Mohamed, A.
    Hoehn, R.
    Miller-Ocuin, J.
    Mahipal, A.
    Shreenivas, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S203 - S203
  • [43] Genomic alterations in DNA mismatch repair (dMMR)
    Holla, Vijaykumar
    Ronaghy, Arash
    Yang, Richard K.
    Patel, Keyur P.
    Routbort, Mark J.
    Overman, Michael J.
    Dumbrava, Ecaterina E.
    Shaw, Kenna R.
    Karp, Daniel D.
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
    Mestrallet, Guillaume
    Brown, Matthew
    Bozkus, Cansu Cimen
    Bhardwaj, Nina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer
    Thomas, Jane
    Leal, Alexis
    Overman, Michael J.
    CLINICAL COLORECTAL CANCER, 2020, 19 (02) : 73 - 81
  • [46] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Dionisia Quiroga
    H. Kim Lyerly
    Michael A. Morse
    Current Treatment Options in Oncology, 2016, 17
  • [47] "Matching" the "Mismatch" Repair-Deficient Prostate Cancer with Immunotherapy
    Schweizer, Michael T.
    Yu, Evan Y.
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 981 - 983
  • [48] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Quiroga, Dionisia
    Lyerly, H. Kim
    Morse, Michael A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)
  • [49] Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
    Panagiotis Sarantis
    Evangelos Koustas
    Adriana Papadimitropoulou
    Athanasios G Papavassiliou
    Michalis V Karamouzis
    World Journal of Gastrointestinal Oncology, 2020, 12 (02) : 173 - 181
  • [50] Mismatch Repair Protein Expression Analysis in Pancreatic Ductal Adenocarcinoma Shows Reduced Expression of MSH6
    Lee, Anna
    Remotti, Helen
    Iuga, Alina
    MODERN PATHOLOGY, 2019, 32
12345